Advertisement

Research Article Free access | 10.1172/JCI118398

Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice.

T Tsujinaka, J Fujita, C Ebisui, M Yano, E Kominami, K Suzuki, K Tanaka, A Katsume, Y Ohsugi, H Shiozaki, and M Monden

Department of Surgery II, Osaka University Medical School, Suita, Japan.

Find articles by Tsujinaka, T. in: JCI | PubMed | Google Scholar

Department of Surgery II, Osaka University Medical School, Suita, Japan.

Find articles by Fujita, J. in: JCI | PubMed | Google Scholar

Department of Surgery II, Osaka University Medical School, Suita, Japan.

Find articles by Ebisui, C. in: JCI | PubMed | Google Scholar

Department of Surgery II, Osaka University Medical School, Suita, Japan.

Find articles by Yano, M. in: JCI | PubMed | Google Scholar

Department of Surgery II, Osaka University Medical School, Suita, Japan.

Find articles by Kominami, E. in: JCI | PubMed | Google Scholar

Department of Surgery II, Osaka University Medical School, Suita, Japan.

Find articles by Suzuki, K. in: JCI | PubMed | Google Scholar

Department of Surgery II, Osaka University Medical School, Suita, Japan.

Find articles by Tanaka, K. in: JCI | PubMed | Google Scholar

Department of Surgery II, Osaka University Medical School, Suita, Japan.

Find articles by Katsume, A. in: JCI | PubMed | Google Scholar

Department of Surgery II, Osaka University Medical School, Suita, Japan.

Find articles by Ohsugi, Y. in: JCI | PubMed | Google Scholar

Department of Surgery II, Osaka University Medical School, Suita, Japan.

Find articles by Shiozaki, H. in: JCI | PubMed | Google Scholar

Department of Surgery II, Osaka University Medical School, Suita, Japan.

Find articles by Monden, M. in: JCI | PubMed | Google Scholar

Published January 1, 1996 - More info

Published in Volume 97, Issue 1 on January 1, 1996
J Clin Invest. 1996;97(1):244–249. https://doi.org/10.1172/JCI118398.
© 1996 The American Society for Clinical Investigation
Published January 1, 1996 - Version history
View PDF
Abstract

The muscles of IL-6 transgenic mice suffer from atrophy. Experiments were carried out on these transgenic mice to elucidate activation of proteolytic systems in the gastrocnemius muscles and blockage of this activation by treatment with the anti-mouse IL-6 receptor (mIL-6R) antibody. Muscle atrophy observed in 16-wk-old transgenic mice was completely blocked by treatment with the mIL-6R antibody. In association with muscle atrophy, enzymatic activities and mRNA levels of cathepsins (B and L) and mRNA levels of ubiquitins (poly- and mono-ubiquitins) increased, whereas the mRNA level of muscle-specific calpain (calpain 3) decreased. All these changes were completely eliminated by treatment with the mIL-6R antibody. This IL-6 receptor antibody could, therefore, be effective against muscle wasting in sepsis and cancer cachexia, where IL-6 plays an important role.

Version history
  • Version 1 (January 1, 1996): No description
Advertisement
Advertisement